05:13 PM EST, 11/25/2025 (MT Newswires) -- Arrowhead Pharmaceuticals ( ARWR ) reported a fiscal-year 2025 loss late Tuesday of $0.01 per diluted share, narrower than a loss of $5.00 a year earlier.

Analysts polled by FactSet expected $0.15.

Revenue for the fiscal-year ended Sept. 30 was $829.4 million, compared with $3.6 million a year earlier.

Analysts surveyed by FactSet expected $761.2 million.